Page last updated: 2024-10-18

ethanolamine and Psoriasis

ethanolamine has been researched along with Psoriasis in 1 studies

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research Excerpts

ExcerptRelevanceReference
"Psoriasis is an inflammatory skin disease that is characterized by keratinocyte hyperproliferation, abnormal epidermal differentiation and dysregulated lipid metabolism."1.91N-eicosapentaenoyl-ethanolamine decreases the proliferation of psoriatic keratinocytes in a reconstructed psoriatic skin model. ( Flamand, N; Morin, S; Pouliot, R; Rioux, G; Simard, M; Tremblay, A, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Simard, M1
Tremblay, A1
Morin, S1
Rioux, G1
Flamand, N1
Pouliot, R1

Other Studies

1 other study available for ethanolamine and Psoriasis

ArticleYear
N-eicosapentaenoyl-ethanolamine decreases the proliferation of psoriatic keratinocytes in a reconstructed psoriatic skin model.
    Scientific reports, 2023, 07-26, Volume: 13, Issue:1

    Topics: Cell Proliferation; Ethanolamine; Ethanolamines; Humans; Keratinocytes; Monoacylglycerol Lipases; Ps

2023